Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112358389B reveals a green LED-driven route for 2-MNQ. Eliminate chromium waste and reduce costs in vitamin K3 manufacturing with our scalable photochemical technology.
Patent CN118388585A enables high-yield amide synthesis with low racemization. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118388585A reveals green visible light catalysis for amide synthesis. Reduces racemization and enhances supply chain reliability for pharmaceutical intermediates globally.
Novel photocatalytic route for SC 69124 ensures high purity and supply continuity. Reduces complexity in pharmaceutical intermediates manufacturing for global partners.
Patent CN112358389A details a green LED-driven synthesis of Vitamin K3 intermediate, offering metal-free production and superior purity for reliable supply chains.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Patent CN106977488B reveals visible light promoted synthesis. Offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN112480020A details a green visible light method for synthesizing benzoxazoles. This report analyzes cost reduction and supply chain reliability for pharma intermediates.
Patent CN119912363A reveals a metal-free photoredox method for alpha-aryl cyclic ketones. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN108586283A enables visible-light synthesis of alpha-azide ketones using air oxidant. Reduces metal waste and offers cost-effective pharmaceutical intermediate manufacturing solutions.
Novel visible-light method for isoquinoline derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN109705006B reveals a green, visible-light method for diaryl sulfides. Eliminate metal residues and reduce costs in pharmaceutical intermediate manufacturing.
Patent CN109705006B details a green, visible-light method for diaryl sulfides, offering cost reduction and metal-free purity for pharmaceutical intermediates manufacturing.
Patent CN116178243A reveals a mild visible-light photocatalytic method for carbazole synthesis, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN116621855B reveals a novel photocatalytic route for Rubescensine A derivatives, offering enhanced solubility and streamlined manufacturing for pharmaceutical intermediates.
Novel photocatalytic trifluoromethylation of aniline drugs improves anticancer activity. Efficient, mild synthesis for reliable pharmaceutical intermediate supply.
Novel Ir-catalyzed visible light method for cyclopropanation. Offers mild conditions and high functional group tolerance for pharmaceutical intermediates.
Patent CN114044751A discloses a scalable synthesis of PhthSCF2D. This stable reagent enables high-purity deuteration in drug molecules, offering significant supply chain advantages.
Patent CN110550992A reveals green photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.